Royalty Pharma plc Reports annual revenue of $2.4 billion

Royalty Pharma plc [RPRX] has reported $2.4 billion in revenue for year ended Dec 31, 2023. 

Also Read: PureTech Health and Royalty Pharma Enter into KarXT Royalty Agreement for up to $500 Million  

The company said in a filing before the Securities and Exchange Commission that its profit for the year was $1.7 billion. 

Also Read: Royalty Pharma to Present at the J.P. Morgan Healthcare Conference on January 9